Alpha CognitionACOG 32 PS Ratio is 11.59 as of Jun. 27, 2026, which is 14% below its 10-year median of 13.49. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 936 Biotechnology companies, Alpha Cognition ranks worse than 55.77% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Alpha Cognition's share price is $6.50.
Alpha Cognition's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.56. Hence, Alpha Cognition's PS Ratio for today is 11.59.
The historical rank and industry rank for Alpha Cognition's PS Ratio or its related term are showing as below:
ACOG'
s PS Ratio Range Over the Past 10 Years
Min: 8.3 Med: 13.49 Max: 51.23
Current: 11.59
During the past 6 years, Alpha Cognition's highest PS Ratio was 51.23. The lowest was 8.30. And the median was 13.49.
ACOG's PS Ratio is ranked worse than 55.77% of 936
companies
in the Biotechnology industry
Industry Median: 9.165
vs ACOG: 11.59
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Alpha Cognition PS Ratio Related Terms
Alpha Cognition PS Ratio Historical Data
* Premium members only.
The historical data trend for Alpha Cognition's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Alpha Cognition's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Cognition PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Cognition's PS Ratio distribution charts can be found below:
* The bar in red indicates where Alpha Cognition's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Alpha Cognition's Share Price of today is $6.50. Alpha Cognition's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Alpha Cognition (ACOG) has a PS Ratio of 11.59 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Alpha Cognition and its competitors. This is 14% below median its historical median of 13.49. Over the past decade, Alpha Cognition's PS Ratio has ranged from 8.30 to 51.23. According to the industry distribution chart, Alpha Cognition ranks #522 out of 936 companies in the Biotechnology industry, placing it in the top 55.8%.
Is Alpha Cognition's PS Ratio too high?
Alpha Cognition's current PS Ratio of 11.59 is 14% below median its 10-year median of 13.49. Over the past 10 years, this metric has ranged from a low of 8.30 to a high of 51.23. The Biotechnology industry median PS Ratio is 9.17. Alpha Cognition's value of 11.59 is 26.5% above this industry median. Based on the distribution chart, Alpha Cognition ranks #522 out of 936 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's PS Ratio compare to GNLX and VTVT?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #522 out of 936 companies for PS Ratio. This places Alpha Cognition in the lower half of its industry. The industry median PS Ratio is 9.17. Alpha Cognition's value of 11.59 is 26.5% above this benchmark. Historically, Alpha Cognition's own PS Ratio has ranged from 8.30 to 51.23 over the past decade. While the company's 10-year median is 13.49 vs. the industry median of 9.17, Alpha Cognition has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.17, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current PS Ratio of 11.59 is 26.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Alpha Cognition and its competitors. For the Biotechnology industry, the median PS Ratio is 9.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current PS Ratio is 11.59, which is 14% below median its own 10-year median of 13.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current PS Ratio of 11.59. The current PS Ratio is 11.59, which is 14% below median its 10-year median of 13.49 and 26.5% above the Biotechnology industry median of 9.17. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current PS Ratio is 11.59 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score
Get the complete analysis for ACOG
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACOG has been successfully added to your 
